Loading…
Probiotics, despite being a significant factor in healthcare spending, often lack robust evidence to support their use. Consequently, their actual impact on human health remains a topic of ongoing debate.
Selecting an appropriate probiotic is challenging because various factors come into play: the strain- and disease-specific efficacy of probiotic products, differences in the mechanisms of action of different probiotic strains, differences in manufacturing processes and quality control of the products, and differences in international regulatory requirements. International guidelines from infectious disease or pediatric disease organizations do not always agree on which probiotics should be used for which type of disease.
The usefulness of probiotics is known through antibiotic-based therapy to decrease blood cholesterol level, the treatment of local infections, and others
Over the past 10 years, a number of clinical studies have investigated the potential of probiotic bacteria to ameliorate the pathological features of allergic disease
Probiotics (living agents) have been scientifically and/or clinically proven to improve intestinal health
Andersson et al. 2001 Scand J Nutr. 45: 58–75
Salminen 2001 Scand J Nutr. 45: 8–12
see also:
Approvals / Regulatory affairs & Probiotics (living agents)
Diseases / Disorders (extraintestinal manifestations)
Diseases / Disorders (intestinal manifestations)
Health & Probiotics (living agents)
Microbiome-based therapeutics